North America Contraceptive Devices Market 2021 Analysis By Regional, Outlook, Competitive Landscape Strategies And Forecast 2028

The market analysis and insights included in the world class North America Contraceptive Devices Market report presents key statistics on the market status of global and regional manufacturers and is an essential source of guidance which provides right direction to the companies and individuals interested in the industry. Also, this market analysis report gives an in-depth knowledge on what the recent developments, product launches are, while also keeping the track for recent acquisitions, mergers, joint ventures and competitive research in the global market industry. By attaining an actionable market insight via North America Contraceptive Devices Market analysis report, sustainable and gainful business strategies can be built.

North America contraceptive devices market is registering a substantial CAGR in the forecast period of 2019-2026. This rise in the market can be attributed to the initiatives taken by government and NGO’s about contraceptives and regular advancement in technologies is contributing to the market growth

Download Exclusive Sample (350 Pages PDF) Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-contraceptive-devices-market

Major Market Key Players:

Teva Pharmaceutical Industries Ltd.
Mona Lisa N.V.
DKT INTERNATIONAL
OCON Medical Ltd.
Pregna International Limited.
Medical Engineerign Corporation S.A.
SMB Corporation of India
Meril Life Sciences Pvt. Ltd.
MEDinCN.com Limited and licensors.
Bernstein Liebhard LLP.
A.M.E. bvba
Technico Industries Ltd.
The Latest Free TOC of This Report @ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-contraceptive-devices-market

Segmentation: North America Contraceptive Devices Market
By Product Type

Male Contraceptive Devices
Female Contraceptive Devices
Female Condoms, Diaphragms & Sponges
Vaginal Rings
Intrauterine Devices
Sub-dermal Implants
Others
By Technology

Hormonal Contraceptives
Barrier Contraceptives
By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channel
Public Channel & NGOs
Others
By Country

U.S.
Canada
Mexico
Key Developments in the Market:

In August 2018, TherapeuticsMD Inc. had received the US FDA approval of ANNOVERA which is reversible & procedure-free birth control prescription and patient-controlled. It is a soft flexible ring which can control the ovulation for the period of a year which can be removed and inserted by the women in a cycle. The approval for the product had expanded the customer base in the USA.
In July 2018, Lupin had launched Norgestimate and ehtinyl estradiol generic oral contraceptive tablets in the U.S. markets after receiving nod from the US FDA. The tablet will prevent the pregnancy. The tablet will be available in the 0.18mg, 0.215mg, and 0.25mg. The launch will expand the product portfolio in the U.S. market.
Access Full Report: https://www.databridgemarketresearch.com/reports/north-america-contraceptive-devices-market

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

About Us:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies ly and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others. We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others.

This release was published on openPR.